Akebia Therapeutics, Inc. - AKBA

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Pharmaceutical Preparations
Latest data: 4/2/2026 10:07:19 PM
EDGAR CIK 0001517022

Buy Breakdown

Total $86,588

Sell Breakdown

Total $1,099,466

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
03/04/2026
03/05/2026
Butler John P.
CEO and President
CEO Director
Buy
69,270 @ $1.25
$86,587.50
 3,367,064 (2.10%) Direct
02/02/2026
10b5-1
02/04/2026
Burke Steven Keith
SVP, Chief Medical Officer
Officer
Sell
-67,658 @ $1.39
($94,044.62)
 948,432 (-6.66%) Direct
02/02/2026
10b5-1
02/04/2026
Butler John P.
CEO and President
CEO Director
Sell
-341,305 @ $1.39
($474,413.95)
 3,297,794 (-9.38%) Direct
02/02/2026
10b5-1
02/04/2026
Grund Nicholas
Chief Commercial Officer
Officer
Sell
-84,829 @ $1.39
($117,912.31)
 561,750 (-13.12%) Direct
02/02/2026
10b5-1
02/04/2026
Malabre Richard C
SVP, Chief Accounting Officer
Officer
Sell
-49,524 @ $1.39
($68,838.36)
 299,390 (-14.19%) Direct
02/02/2026
10b5-1
02/04/2026
Ostrowski Erik
SVP, CFO, CBO & Treasurer
CFO
Sell
-34,951 @ $1.39
($48,581.89)
 672,635 (-4.94%) Direct
02/02/2026
10b5-1
02/04/2026
Rucci Carolyn M.
SVP, Chief Legal Officer
Officer
Sell
-69,772 @ $1.39
($96,983.08)
 588,378 (-10.60%) Direct
06/30/2025
10b5-1
07/01/2025
Ostrowski Erik
SVP, CFO, CBO & Treasurer
CFO
Sell
-41,314 @ $3.67
($151,622.38)
 503,586 (-7.58%) Direct
06/04/2025
10b5-1
06/05/2025
Malabre Richard C
SVP, Chief Accounting Officer
Officer
Sell
-13,334 @ $3.53
($47,069.02)
 266,914 (-4.76%) Direct